Bruland ØS - Search Results

1

Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy.

Berg A, Berner A, Lilleby W, Bruland ØS, Fosså SD, Nesland JM, Kvalheim G. Berg A, et al. Among authors: bruland os. Int J Cancer. 2007 Apr 15;120(8):1603-9. doi: 10.1002/ijc.22488. Int J Cancer. 2007. PMID: 17230512

2

Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model.

Vergote I, Larsen RH, de Vos L, Nesland JM, Bruland O, Bjørgum J, Alstad J, Tropé C, Nustad K. Vergote I, et al. Gynecol Oncol. 1992 Dec;47(3):366-72. doi: 10.1016/0090-8258(92)90141-5. Gynecol Oncol. 1992. PMID: 1473751

3

Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma.

Fodstad O, Brøgger A, Bruland O, Solheim OP, Nesland JM, Pihl A. Fodstad O, et al. Int J Cancer. 1986 Jul 15;38(1):33-40. doi: 10.1002/ijc.2910380107. Int J Cancer. 1986. PMID: 3459716

4

Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation. A study of 49 primary tumours, recurrences and metastases.

Lopes JM, Bjerkehagen B, Holm R, Bruland O, Sobrinho-Simões M, Nesland JM. Lopes JM, et al. Pathol Res Pract. 1994 Feb;190(2):168-77. doi: 10.1016/S0344-0338(11)80708-9. Pathol Res Pract. 1994. PMID: 7520165

5

Proliferative activity of synovial sarcoma: an immunohistochemical evaluation of Ki-67 labeling indices of 52 primary and recurrent tumors.

Lopes JM, Bjerkehagen B, Holm R, Bruland O, Sobrinho-Simões M, Nesland JM. Lopes JM, et al. Ultrastruct Pathol. 1995 Mar-Apr;19(2):101-6. doi: 10.3109/01913129509014609. Ultrastruct Pathol. 1995. PMID: 7792946

6

p53 abnormalities in different subtypes of human sarcomas.

Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL, et al. Andreassen A, et al. Among authors: bruland os. Cancer Res. 1993 Feb 1;53(3):468-71. Cancer Res. 1993. PMID: 8425179

7

Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance.

Lopes JM, Bruland OS, Bjerkehagen B, Silva MC, Holm R, Pettersen EO, Solheim OP, Sobrinho-Simões M, Nesland JM. Lopes JM, et al. Among authors: bruland os. Pathol Res Pract. 1997;193(1):21-36. doi: 10.1016/s0344-0338(97)80090-8. Pathol Res Pract. 1997. PMID: 9112270

8

Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers.

Lopes JM, Hannisdal E, Bjerkehagen B, Bruland OS, Danielsen HE, Pettersen EO, Sobrinho-Simões M, Nesland JM. Lopes JM, et al. Among authors: bruland os. Anal Cell Pathol. 1998;16(1):45-62. doi: 10.1155/1998/545906. Anal Cell Pathol. 1998. PMID: 9584899 Free PMC article. Review.

9

Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells.

Aurlien E, Larsen RH, Kvalheim G, Bruland OS. Aurlien E, et al. Among authors: bruland os. Br J Cancer. 2000 Nov;83(10):1375-9. doi: 10.1054/bjoc.2000.1453. Br J Cancer. 2000. PMID: 11044364 Free PMC article.

10

First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases.

Nilsson S, Larsen RH, Fosså SD, Balteskard L, Borch KW, Westlin JE, Salberg G, Bruland OS. Nilsson S, et al. Among authors: bruland os. Clin Cancer Res. 2005 Jun 15;11(12):4451-9. doi: 10.1158/1078-0432.CCR-04-2244. Clin Cancer Res. 2005. PMID: 15958630 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters